Region: China
Category: Biosimilars
Category: Biosimilars
China Biosimilars
(3 reports matching your criteria)
-
2024 China Biosimilars Forecast (2025-2030 Outlook)-Market Opportunities Report
... market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published historically ... Read More
-
Asia Pacific Next Generation Antibody Market, By Therapeutic Area (Oncology, Autoimmune/Inflammatory); By Technology (Antibody-Drug Conjugates (ADC's), Bispecific Antibodies, FC Engineered Antibodies, Antibody Fragments and Antibody-like Proteins, Biosimilar Antibody Products); By Country (China, India, Japan, South Korea, Indonesia, Vietnam, Malaysia, Rest of Asia Pacific), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... antibody research and development programs, advancements in biotechnology, and expanding healthcare infrastructure. BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Asia Pacific Next Generation Antibody Market size ... Read More
-
CHINA DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... WHO, 20% of persons with diabetes and diabetes-related disorders died in China in January 2020 COVID-19 fatalities. Diabetes affects about one out of every ten COVID-19 patients in China. Diabetes is linked to an increased ... Read More
Research Assistance
